Traws Pharma, Inc. Gain (Loss) on Disposition of Assets
Traws Pharma, Inc. (TRAW) reported Gain (Loss) on Disposition of Assets of -$22.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-29.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2017-03-29
- Traws Pharma, Inc. gain (loss) on disposition of assets for the quarter ending 2015-12-31 was $0.00.
- Traws Pharma, Inc. gain (loss) on disposition of assets for the quarter ending 2015-09-30 was $0.00.
- Traws Pharma, Inc. gain (loss) on disposition of assets for fiscal 2015 was -$22.00K.
- Traws Pharma, Inc. gain (loss) on disposition of assets for fiscal 2012 was -$3.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | -$22.00K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$22.00K 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | -$22.00K 10-Q · filed 2016-08-15 | |||
| 2012-12-31 | -$3.00K 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |